195
Views
7
CrossRef citations to date
0
Altmetric
Articles

Anti-oxidative effect of the tyrosine kinase inhibitor nintedanib: a potential therapy for chronic lung allograft dysfunction?

, , &
Pages 128-145 | Received 05 Apr 2019, Accepted 02 Mar 2020, Published online: 13 Mar 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Articles from other publishers (5)

Lin Pan, Yiju Cheng, Wenting Yang, Xiao Wu, Honglan Zhu, Meigui Hu, Yuquan Zhang & Menglin Zhang. (2023) Nintedanib Ameliorates Bleomycin-Induced Pulmonary Fibrosis, Inflammation, Apoptosis, and Oxidative Stress by Modulating PI3K/Akt/mTOR Pathway in Mice. Inflammation 46:4, pages 1531-1542.
Crossref
M. Bozkurt, E.C. Polat, L. Ozcan, M. Ozer, G.Y. Ozturk, F. Yildirim & A. Otunctemur. (2023) Effect of Nintedanib on healing and fibrosis in rats with experimentally induced urethral injury. Progrès en Urologie 33:7, pages 393-400.
Crossref
Muhammet Ali Beyoglu, Mehmet Furkan Sahin, Sinan Turkkan, Alkin Yazicioglu, Emis Deniz Akbulut, Salim Neselioglu, Ozcan Erel & Erdal Yekeler. (2022) Dynamic Thiol-Disulfide Homeostasis in Lung Transplant Recipients. Experimental and Clinical Transplantation.
Crossref
Saskia Bos, Laurens J. De Sadeleer, Arno Vanstapel, Hanne Beeckmans, Annelore Sacreas, Jonas Yserbyt, Wim A. Wuyts & Robin Vos. (2021) Antifibrotic drugs in lung transplantation and chronic lung allograft dysfunction: a review. European Respiratory Review 30:160, pages 210050.
Crossref
Alessandro G. Fois, Elisabetta Sotgiu, Valentina Scano, Silvia Negri, Sabrina Mellino, Elisabetta Zinellu, Pietro Pirina, Gianfranco Pintus, Ciriaco Carru, Arduino A. Mangoni & Angelo Zinellu. (2020) Effects of Pirfenidone and Nintedanib on Markers of Systemic Oxidative Stress and Inflammation in Patients with Idiopathic Pulmonary Fibrosis: A Preliminary Report. Antioxidants 9:11, pages 1064.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.